David McDermott, M.D., describes a high dose IL-2 clinical trial for kidney cancer that is available nationally.
Views:
1,724
Rating:
Comments
I really wish one day there is an effective treatment for this chronic disease. My Father died of the same even though we tried latest drugs like Nexavar (Sorafenib) and Sutent (Sunitinib).
when IL-2 is administered the patients shake like someone standing outside in Fargo ND on March 23, 2008 at 10:42 A.M.
Del.icio.us
Digg
Facebook
StumbleUpon